Literature DB >> 22245830

Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells.

Sylvain Bellanger1, Marie-Claude Battista, Guy D Fink, Jean-Patrice Baillargeon.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is mainly defined by hyperandrogenemia, from ovarian and adrenal origin, and is characterized by insulin resistance (IR). Studies found that raising in vivo non-esterified fatty acid (NEFA) levels, which induces lipotoxicity, increases androgen levels and IR. The aim of this study was therefore to determine the effects of in vitro over-exposure to NEFA on androgen synthesis in a bovine adrenocortical cell model.
METHODS: Bovine fasciculata/reticularis cells were cultured for 2days in the absence or presence of ACTH (10nmol/L) or Forskolin (fsk, 10μmol/L), alone or in combination with the saturated fatty acid (FA) palmitate (100μmol/L). Steroid production was measured in medium and corrected for initial cell seeding count. CYP17 protein expression and ERK1/2 phosphorylation were assessed by Western blotting.
RESULTS: Under unstimulated conditions, dehydroepiandrosterone (DHEA) levels were barely detected and no difference was observed after palmitate exposure, which was also the case for CYP17 expression and ERK1/2 phosphorylation. Under stimulation, palmitate exposure increased DHEA production by 38% and 69%, for ACTH and fsk, respectively, as compared to untreated conditions (Ps⩽0.05). In palmitate-treated vs untreated cells, fsk-stimulated ERK1/2 phosphorylation was reduced by 46% (P=0.0047), but stimulated CYP17 expression was not significantly affected.
CONCLUSION: In a model of androgen-producing cells, under stimulated conditions, overexposure to saturated FAs significantly increases androgen production and reduces MEK/ERK activation. Therefore, this study is the first to demonstrate that lipotoxicity can directly trigger androgen overproduction in vitro, in addition to its well-described impact on IR, which strongly supports a central role of lipotoxicity in PCOS pathophysiology. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245830      PMCID: PMC3848974          DOI: 10.1016/j.steroids.2011.12.017

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  34 in total

1.  Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.

Authors:  Louise Mannerås-Holm; Henrik Leonhardt; Joel Kullberg; Eva Jennische; Anders Odén; Göran Holm; Mikael Hellström; Lars Lönn; Gunilla Olivecrona; Elisabet Stener-Victorin; Malin Lönn
Journal:  J Clin Endocrinol Metab       Date:  2010-11-17       Impact factor: 5.958

2.  Adrenocorticotropin/cyclic adenosine 3',5'-monophosphate-mediated transcription of the human CYP17 gene in the adrenal cortex is dependent on phosphatase activity.

Authors:  Marion B Sewer; Michael R Waterman
Journal:  Endocrinology       Date:  2002-05       Impact factor: 4.736

Review 3.  The regulation of 17,20 lyase activity.

Authors:  W L Miller; R J Auchus; D H Geller
Journal:  Steroids       Date:  1997-01       Impact factor: 2.668

4.  Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity.

Authors:  I Usui; Y Takata; T Imamura; H Morioka; T Sasaoka; T Sawa; H Ishihara; M Ishiki; M Kobayashi
Journal:  Diabetologia       Date:  1997-08       Impact factor: 10.122

Review 5.  Dysfunctional fat cells, lipotoxicity and type 2 diabetes.

Authors:  R A DeFronzo
Journal:  Int J Clin Pract Suppl       Date:  2004-10

6.  Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.

Authors:  Jean-Patrice Baillargeon; Daniela J Jakubowicz; Maria J Iuorno; Salomon Jakubowicz; John E Nestler
Journal:  Fertil Steril       Date:  2004-10       Impact factor: 7.329

Review 7.  Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes.

Authors:  André C Carpentier
Journal:  Diabetes Metab       Date:  2008-03-18       Impact factor: 6.041

8.  Down-regulation of steroidogenic response to gonadotropins in human and rat preovulatory granulosa cells involves mitogen-activated protein kinase activation and modulation of DAX-1 and steroidogenic factor-1.

Authors:  Kimihisa Tajima; Ada Dantes; Zhong Yao; Ksenia Sorokina; Fumikazu Kotsuji; Rony Seger; Abraham Amsterdam
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

9.  Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.

Authors:  M Ciampelli; A M Fulghesu; F Cucinelli; V Pavone; A Caruso; S Mancuso; A Lanzone
Journal:  Hum Reprod       Date:  1997-09       Impact factor: 6.918

10.  CAMP-dependent protein kinase enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells.

Authors:  Marion B Sewer; Michael R Waterman
Journal:  J Biol Chem       Date:  2002-12-27       Impact factor: 5.157

View more
  13 in total

Review 1.  PCOS in adolescence and type 2 diabetes.

Authors:  Anne-Marie Carreau; Jean-Patrice Baillargeon
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

2.  Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.

Authors:  Uche Ezeh; Zorayr Arzumanyan; Daria Lizneva; Ruchi Mathur; Yen-Hao Chen; Raymond C Boston; Y-D Ida Chen; Ricardo Azziz
Journal:  Hum Reprod       Date:  2019-02-01       Impact factor: 6.918

3.  Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome.

Authors:  Leah D Whigham; Daniel E Butz; Hesam Dashti; Marco Tonelli; Luann K Johnson; Mark E Cook; Warren P Porter; Hamid R Eghbalnia; John L Markley; Steven R Lindheim; Dale A Schoeller; David H Abbott; Fariba M Assadi-Porter
Journal:  Curr Metabolomics       Date:  2014

Review 4.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

5.  Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome.

Authors:  Andréanne Trottier; Marie-Claude Battista; David H Geller; Brigitte Moreau; André C Carpentier; Judith Simoneau-Roy; Jean-Patrice Baillargeon
Journal:  Fertil Steril       Date:  2012-09-15       Impact factor: 7.329

Review 6.  Normal and Premature Adrenarche.

Authors:  Robert L Rosenfield
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

7.  Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome.

Authors:  Soren Harnois-Leblanc; Andréanne Trottier; Samuel Leblanc; Marie-Claude Battista; David H Geller; Jean-Patrice Baillargeon
Journal:  Reprod Biol Endocrinol       Date:  2017-07-24       Impact factor: 5.211

Review 8.  Non-esterified fatty acids in the ovary: friends or foes?

Authors:  Vijay Simha Baddela; Arpna Sharma; Jens Vanselow
Journal:  Reprod Biol Endocrinol       Date:  2020-06-06       Impact factor: 5.211

Review 9.  Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome.

Authors:  Alexandre Connolly; Samuel Leblanc; Jean-Patrice Baillargeon
Journal:  Int J Endocrinol       Date:  2018-06-03       Impact factor: 3.257

Review 10.  The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms.

Authors:  Nan-Xing Jiang; Xue-Lian Li
Journal:  Reprod Sci       Date:  2021-05-27       Impact factor: 2.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.